Seeing double: Designing drugs that target twin cancer proteins Scripps Research scientists used knowledge about a protein to characterize drugs that selectively bind to its twin, or paralog.
September 30, 2024
LA JOLLA, CA Some proteins in the human body are easy to block with a drug; they have an obvious spot in their structure where a drug can fit, like a key in a lock. But other proteins are more difficult to target, with no clear drug-binding sites.
To design a drug that blocks a cancer-related protein, Scripps Research scientists took a hint from the protein's paralog, or twin. Using innovative chemical biology methods, the scientists pinpointed a druggable site on the paralog, and then used that knowledge to characterize drugs that bound to a similar but more difficult to detect spot on its twin. Ultimately, they found drugs that only bound to the protein of interest and not its highly similar sibling.
Their approach, described in Nature Chemical Biology on September 18, 2024, and dubbed paralog hopping, could uncover new binding sites for drugs and inform drug development more broadly, since nearly half of the proteins in human cells including many involved in cancer and autoimmune diseases have such paralogs.
This method may be generally useful in cases where you have paralogs, and you are trying to find a new drug for one of them, says senior author Benjamin Cravatt, PhD, the Norton B. Gilula Chair in Biology and Chemistry at Scripps Research. Being able to target one paralog over another is an important goal in drug development, as two paralogs often have different functions.
Many genes have duplicated throughout evolution, resulting in multiple copies in the human genome. In some cases, copies have evolved slightly different sequences from each other, making their corresponding proteins into paralogs. These protein paralogs remain highly similar in structure and often have redundant or overlapping functions within cells.
In recent years, Cravatt's research team formulated an approach to develop drugs that bind to the amino acid cysteine a protein building block with unique, highly reactive chemical properties. The scientists' method takes advantage of cysteines as an optimal site for drugs to attach to a protein permanently, often inactivating it. However, not all proteins have accessible cysteines. In the cases of paralog pairs, one protein may have a druggable cysteine that the other does not.
We started with this idea that if you know how to drug one protein, you can figure out how to drug its paralog in a similar way, says Yuanjin Zhang, a graduate student at Scripps Research and first author of the new paper.
As a test case, the team tackled the paralog pair known as CCNE1 and CCNE2. Both proteins have been found to be overactive in breast, ovarian and lung cancer. However, scientists suspected that the two proteins play slightly different roles. The team posited that turning off just one protein could make treating some cancers more effective.
It has been difficult, however, to design drugs that target the CCNE1 and CCNE2 proteins to test this hypothesis. Cravatt, Zhang and their colleagues knew that CCNE2 had a druggable cysteine, while CCNE1 did not. If they could identify drugs that bound to the same spot on CCNE1, even in the absence of a cysteine, they suspected the protein would shut off.
The scientists first engineered a cysteine into CCNE1, mimicking the drug-binding spot they had pinpointed in CCNE2. They then leveraged this neo-cysteine to identify drugs that bind to CCNE1. Next, they screened a library of other chemical compounds for the ability to compete with that drug in binding to CCNE1. The team reasoned that some of the compounds that competed for the same spot would bind in ways that did not rely on the cysteine.
Indeed, Cravatt, Zhang and their colleagues discovered multiple compounds that could bind to the same site on CCNE1 even when the cysteine was removed again. Some compounds did not bind to CCNE2. Some also had opposite functions, stabilizing the molecule so that it might be more active than usual, rather than inactivating it. Structural studies revealed that the CCNE1 compounds bind to a cryptic pocket that was not previously known to be druggable.
The team says the approach highlights the importance of screening for drugs in diverse, creative ways.
If we had just screened looking for compounds with a particular function, we would not have identified all of these various functional molecules, and if we had just looked at the structure of CCNE1, we would not have found this binding pocket at all, says Zhang.
More research is needed to discover whether the new compounds have potential utility in treating cancer or other diseases in which CCNE1 plays a role. Next, the scientists plan to apply their paralog-hopping method to other pairs of proteins important for tumorigenesis.
In addition to Cravatt and Zhang, authors of the study, An allosteric cyclin E-CDK2 site mapped by paralog hopping with covalent probes, include Zhonglin Liu, Sang Joon Won, Divya Bezwada and Bruno Melillo of Scripps Research; and Marsha Hirschi, Oleg Brodsky, Eric Johnson, Asako Nagata, Matthew D. Petroski, Jaimeen D. Majmudar, Sherry Niessen, Todd VanArsdale, Adam M. Gilbert, Matthew M. Hayward, Al E. Stewart and Andrew R. Nager of Pfizer, Inc.
This work was supported by funding from the National Cancer Institute (R35 CA231991) and Pfizer.
Chemistry Cravatt, Benjamin
Europe Stories
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
07/10/2026
Dalet, a leading technology and service provider for media-rich organizations, today announced the latest Long-Term Supported (LTS) release of Dalet Flex. Build...
06/09/2026
June 9 2026, 23:00 (PDT) Dolby and MagentaTV Bring Fans Closer to the FIFA Worl...
25/08/2026
CUPERTINO, CALIFORNIA Apple today debuted M6 in the new Mac mini and M5 Ultra in...
25/08/2026
CUPERTINO, CALIFORNIA Apple today announced the new Mac mini with the all-new M6...
25/08/2026
CUPERTINO, CALIFORNIA Apple today announced the new Mac Studio, featuring M5 Max...
25/08/2026
The new series begins Tuesday 1 September at 7pm on RT One and RT Player
The search for Ireland's hidden housing gems is back as Cheap Irish Homes return...
24/08/2026
Human-played drum fills on demand
Sample library developers Yurt Rock have announced the launch of a new plug-in that's dedicated to creating drum fill...
24/08/2026
Debut plug-in in new Professional Series
Black Rooster Audio's latest plug-in delivers an all-in-one vocal-processing tool, and is the debut release in ...
24/08/2026
Rohde & Schwarz addresses operational efficiency and infrastructure resilience a...
24/08/2026
The Handel Scandal and Dangerous Debussy will both air on Sky Arts this AutumnMo...
24/08/2026
Dalet, a leading technology and service provider for media-rich organizations, w...
24/08/2026
Arvato Systems Becomes a Service Partner of HANDELSVERBAND.swiss
Zurich - Arvato Systems Switzerland has been a service partner of HANDELSVERBAND.swiss since ...
24/08/2026
We Only Want the Earth: The Life & Ideas of James Connolly airs
Wednesday 26 August on RT One and RT Player at 9.35pm
RT is to air the compelling documenta...
23/08/2026
Offers up to 10 bands of compression
Parish Audio's latest release allows users to place individual compressors anywhere in the frequency range, but tak...
21/08/2026
Hardware-style timing shifts for software instruments
Following on from the release of Omniclock, Rapid Flow have launched a new sequencer plug-in that can ...
21/08/2026
Highly anticipated synthesizer ships in October 2026
Iceland-based Love Synthesizers have announced that their highly anticipated synthesizer is now availab...
21/08/2026
Masterpiece PBS The Forsytes has expanded its cast as its begins production in ...
21/08/2026
The BBC has unveiled first-look pictures from The Witch Farm, a new ghost story and mystery set in the Welsh countryside, coming soon to BBC iPlayer and BBC One...
21/08/2026
The BBC and BritBox have revealed the first look of Edward Bluemel as Hercule Poirot in the forthcoming six-part series Hercule from Mammoth Screen and Agatha C...
21/08/2026
eds3_5_jq(document).ready(function($) { $(#eds_sliderM519).chameleonSlider_2_1({ content_source:......
21/08/2026
** MEDIA ALERT **
VIZ Media Takes Over Anime NYC with BLEACH, BLACK TORCH, M...
21/08/2026
Tell us a little bit about your job I'm a Marketing Manager and work across a mix of clients and projects. No two days are ever quite the same, which defini...
21/08/2026
Beat The Lotto dives into the plot behind the 1980s National Lottery scandal
24 August 2026 at 9:35pm on RT One and RT Player
Beat The Lotto is the story o...
21/08/2026
The countdown to the most wonderful night of the year has officially begun!
Host Patrick Kielty is gearing up for another unforgettable Late Late Toy Show nig...
21/08/2026
Meet puppet duo Bellie and Whizz, who are about to explore all the big feelings ...
20/08/2026
Set up your own private remote collaboration infrastructure
SoundBridge have recently put together a tutorial video that provides users with a step-by-step ...
20/08/2026
New V-Control Pro features restore basic functionality
Neyrinck's V-Control software has long been keeping older Avid control surfaces compatible with n...
20/08/2026
TV, BritBox and Mammoth Screen have announced that filming is now underway on th...
20/08/2026
Thursday 20 August 2026
Nina Sosanya, Rizzle Kicks, Roman Kemp and Paul Whiteho...
20/08/2026
Wuppertal August 20, 2026
Transformation Church Elevates Production Communicat...
20/08/2026
The music between the notes Coming together In the middle of 2026, as conversations around artificial intelligence continue to raise questions about how musi...
20/08/2026
Arvato Systems Brings Together Digital Transformation Leaders in the Manufacturi...
19/08/2026
Studio owners invited to have their say on rates cuts
The Music Producers Guild (MPG) are inviting UK-based studios to take part in an in-depth survey that ...
19/08/2026
Vintage-inspired desktop interface revealed
Harrison's latest hardware offering sees them head back into the world of audio interfaces, delivering a 10-...
19/08/2026
Granular effect remains locked to scale and tempo
Described as your dream granular effect , Minimal Audio's latest creation is capable of turning any s...
19/08/2026
First polyphonic SWAM instrument incoming
Audio Modeling's latest physical-modelling orchestral instrument is just around the corner, and is now availab...
19/08/2026
There's an early Christmas gift for Bookish fans, as UKTV confirms the re-commission of the hit U&alibi drama, created by and starring Mark Gatiss. Viewers ...
19/08/2026
Wednesday 19 August 2026
Sky gives sports fans the chance to watch multiple liv...
19/08/2026
On Saturday September 5 Katie Taylor will step into the ring for the fight of her life against Flora Pili in front of 80,000 fans in Croke Park. A legendary fig...
18/08/2026
Company launch with stereo-imaging tool
Panoramic is the debut release from Panorama Labs, a new company formed by mastering engineer Nicholas Di Lorenzo. C...
18/08/2026
Control software now available for older interfaces
Focusrite have just announced the launch of an update that extends Control 2 software support for their ...
18/08/2026
Tuesday 18 August 2026
Sky Sports and The Fast and the Curious announce new partnership
Sky Sports and The Fast and the Curious have announced a new long-term...
18/08/2026
Wuppertal August 18, 2026
Riedel Brings Professional Live Production Into the Classrooms of ECURiedel Communications today announced that Edith Cowan Universi...
18/08/2026
Apple today announced changes to its business terms for apps in the European Uni...
18/08/2026
THE HEALY RAES: BLOOD, SWEAT & TEARS AIRS WEDNESDAY AUGUST 19 ON RT ONE AT 9:35PM
A new documentary The Healy-Raes: Blood, Sweat & Tears airs on RT One and ...
18/08/2026
Stunning Irish performances at European Athletics and Swimming Championships rea...
18/08/2026
The two-part series begins Sunday 23 August at 6.30pm on RT One and RT Player
...
17/08/2026
New MIDI processor & macro controller revealed
SHIK have announced that they have opened pre-orders for the S32, a standalone MIDI processor and macro contr...
Seeing double: Designing drugs that target twin cancer proteins Scripps Research scientists used knowledge about a protein to characterize drugs that selectively bind to its twin, or paralog.
